FY2025 EPS Estimates for Tilray Increased by Atb Cap Markets

Tilray Inc (NASDAQ:TLRY) – Stock analysts at Atb Cap Markets raised their FY2025 EPS estimates for shares of Tilray in a note issued to investors on Monday, December 16th. Atb Cap Markets analyst F. Gomes now expects that the company will post earnings of ($0.13) per share for the year, up from their previous estimate of ($0.14). The consensus estimate for Tilray’s current full-year earnings is ($0.14) per share. Atb Cap Markets also issued estimates for Tilray’s FY2026 earnings at ($0.11) EPS, FY2027 earnings at ($0.04) EPS and FY2029 earnings at $0.05 EPS.

Separately, Roth Mkm lowered their target price on Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a research note on Friday, October 11th.

Tilray Trading Up 8.6 %

NASDAQ TLRY opened at $1.26 on Thursday. The company’s fifty day simple moving average is $1.44 and its 200-day simple moving average is $1.65. The stock has a market cap of $1.14 billion, a P/E ratio of -4.67 and a beta of 2.08. Tilray has a 52 week low of $1.14 and a 52 week high of $2.97. The company has a current ratio of 2.47, a quick ratio of 1.57 and a debt-to-equity ratio of 0.08.

Tilray (NASDAQ:TLRY) last issued its earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share for the quarter, hitting the consensus estimate of ($0.04). Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The company had revenue of $200.00 million during the quarter, compared to the consensus estimate of $218.70 million. During the same quarter in the prior year, the business earned ($0.10) earnings per share. The company’s revenue was up 13.0% compared to the same quarter last year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Synovus Financial Corp boosted its stake in Tilray by 176.7% during the 3rd quarter. Synovus Financial Corp now owns 36,092 shares of the company’s stock valued at $64,000 after purchasing an additional 23,046 shares during the period. Barclays PLC grew its holdings in Tilray by 600.4% in the 3rd quarter. Barclays PLC now owns 204,144 shares of the company’s stock worth $359,000 after buying an additional 174,997 shares in the last quarter. Toronto Dominion Bank raised its stake in Tilray by 454.5% during the 3rd quarter. Toronto Dominion Bank now owns 128,923 shares of the company’s stock valued at $227,000 after acquiring an additional 105,671 shares in the last quarter. XTX Topco Ltd grew its stake in shares of Tilray by 1,079.7% in the third quarter. XTX Topco Ltd now owns 281,504 shares of the company’s stock worth $495,000 after purchasing an additional 257,641 shares in the last quarter. Finally, State Street Corp increased its holdings in shares of Tilray by 4.7% during the third quarter. State Street Corp now owns 1,961,338 shares of the company’s stock valued at $3,452,000 after purchasing an additional 88,079 shares during the period. 9.35% of the stock is currently owned by institutional investors.

Insider Activity at Tilray

In other Tilray news, CFO Carl A. Merton purchased 26,000 shares of the firm’s stock in a transaction dated Friday, November 15th. The stock was acquired at an average cost of $1.36 per share, with a total value of $35,360.00. Following the acquisition, the chief financial officer now owns 26,000 shares of the company’s stock, valued at approximately $35,360. This represents a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. 0.87% of the stock is owned by corporate insiders.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.